127 related articles for article (PubMed ID: 6203536)
21. Evidence for the cytotoxic activity of polyglutamate derivatives of methotrexate.
Galivan J
Mol Pharmacol; 1980 Jan; 17(1):105-10. PubMed ID: 6155601
[No Abstract] [Full Text] [Related]
22. Formation of methotrexate polyglutamates in purified myeloid precursor cells from normal human bone marrow.
Koizumi S; Curt GA; Fine RL; Griffin JD; Chabner BA
J Clin Invest; 1985 Mar; 75(3):1008-14. PubMed ID: 2579975
[TBL] [Abstract][Full Text] [Related]
23. Studies on the in vivo synthesis of methotrexate polyglutamates and their efflux properties in normal, proliferative, and neoplastic mouse tissues.
Poser RG; Sirotnak FM
Adv Exp Med Biol; 1983; 163():259-74. PubMed ID: 6193689
[TBL] [Abstract][Full Text] [Related]
24. The kinetics of methotrexate polyglutamation in human breast cancer cells.
Morrison PF; Allegra CJ
Arch Biochem Biophys; 1987 May; 254(2):597-610. PubMed ID: 2437860
[TBL] [Abstract][Full Text] [Related]
25. Role of methotrexate polyglutamates in methotrexate- and sequential methotrexate-5-fluorouracil-mediated cell kill.
McGuire JJ; Mini E; Hsieh P; Bertino JR
Cancer Res; 1985 Dec; 45(12 Pt 1):6395-400. PubMed ID: 2415244
[TBL] [Abstract][Full Text] [Related]
26. The kinetics of methotrexate polyglutamate formation and efflux in a human breast cancer cell line (MDA.MB.436): the effect of insulin.
Kennedy DG; Clarke R; van den Berg HW; Murphy RF
Biochem Pharmacol; 1983 Jan; 32(1):41-6. PubMed ID: 6187348
[No Abstract] [Full Text] [Related]
27. Characteristics of methotrexate polyglutamate formation in cultured hepatic cells.
Balinska M; Nimec Z; Galivan J
Arch Biochem Biophys; 1982 Jul; 216(2):466-76. PubMed ID: 6180686
[No Abstract] [Full Text] [Related]
28. Basis for natural resistance to methotrexate in human acute non-lymphocytic leukemia.
Lin JT; Tong WP; Trippett TM; Niedzwiecki D; Tao Y; Tan C; Steinherz P; Schweitzer BI; Bertino JR
Leuk Res; 1991; 15(12):1191-6. PubMed ID: 1722550
[TBL] [Abstract][Full Text] [Related]
29. Characteristics of the accumulation of methotrexate polyglutamate derivatives in Ehrlich ascites tumor cells and isolated rat hepatocytes.
Fry DW; Gewirtz DA; Yalowich JC; Goldman ID
Adv Exp Med Biol; 1983; 163():215-34. PubMed ID: 6193686
[TBL] [Abstract][Full Text] [Related]
30. Intrinsic resistance of cervical squamous cell carcinoma cell lines to methotrexate (MTX) as a result of decreased accumulation of intracellular MTX polyglutamates.
Barakat RR; Li WW; Lovelace C; Bertino JR
Gynecol Oncol; 1993 Oct; 51(1):54-60. PubMed ID: 7694891
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of human dihydrofolate reductase by antifolyl polyglutamates.
Kumar P; Kisliuk RL; Gaumont Y; Freisheim JH; Nair MG
Biochem Pharmacol; 1989 Feb; 38(3):541-3. PubMed ID: 2465007
[No Abstract] [Full Text] [Related]
32. The reticulocytic rat: a model for analysis of methotrexate polyglutamate dynamics in situ.
Krakower GR; Kamen BA
J Pharmacol Exp Ther; 1984 Oct; 231(1):43-7. PubMed ID: 6208355
[TBL] [Abstract][Full Text] [Related]
33. Cytotoxicity, uptake, polyglutamate formation, and antileukemic effects of 8-deaza analogues of methotrexate and aminopterin in mice.
Kuehl M; Brixner DI; Broom AD; Avery TL; Blakley RL
Cancer Res; 1988 Mar; 48(6):1481-8. PubMed ID: 2449950
[TBL] [Abstract][Full Text] [Related]
34. Effects of D,L-4-fluoroglutamic acid on glutamylation of methotrexate by hepatic cells in vitro.
Galivan J; Coward JK; McGuire JJ
Biochem Pharmacol; 1985 Aug; 34(16):2995-7. PubMed ID: 2411272
[No Abstract] [Full Text] [Related]
35. [Mechanisms of resistance to methotrexate].
Fanin R; Aschele C; Volkendandt M; Trippett TM; Lin JT; Bertino JR
Haematologica; 1991 Jun; 76 Suppl 3():184-7. PubMed ID: 1721601
[No Abstract] [Full Text] [Related]
36. Predictions of a network thermodynamics computer model relating to the mechanism of methotrexate rescue by 5-formyltetrahydrofolate and to the importance of inhibition of thymidylate synthase by methotrexate-polyglutamates.
White JC
Adv Exp Med Biol; 1983; 163():305-26. PubMed ID: 6193692
[TBL] [Abstract][Full Text] [Related]
37. Inherent resistance of human squamous carcinoma cell lines to methotrexate as a result of decreased polyglutamylation of this drug.
Pizzorno G; Chang YM; McGuire JJ; Bertino JR
Cancer Res; 1989 Oct; 49(19):5275-80. PubMed ID: 2475246
[TBL] [Abstract][Full Text] [Related]
38. Mechanisms of sensitivity and natural resistance to antifolates in a methylcholanthrene-induced rat sarcoma.
Li WW; Lin JT; Schweitzer BI; Bertino JR
Mol Pharmacol; 1991 Nov; 40(5):854-8. PubMed ID: 1719370
[TBL] [Abstract][Full Text] [Related]
39. Effects of folinic acid on hepatoma cells containing methotrexate polyglutamates.
Galivan J; Nimec Z
Cancer Res; 1983 Feb; 43(2):551-5. PubMed ID: 6184149
[TBL] [Abstract][Full Text] [Related]
40. Differences in folylpolyglutamate synthetase and dihydrofolate reductase expression in human B-lineage versus T-lineage leukemic lymphoblasts: mechanisms for lineage differences in methotrexate polyglutamylation and cytotoxicity.
Galpin AJ; Schuetz JD; Masson E; Yanishevski Y; Synold TW; Barredo JC; Pui CH; Relling MV; Evans WE
Mol Pharmacol; 1997 Jul; 52(1):155-63. PubMed ID: 9224825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
